BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

BioIVT and KRISHGEN BioSystems Forge Exclusive Agreement to Expand Access to High-Quality Biospecimen Solutions Across South Asia

-BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced an exclusive agreement* with KRI...

November 07, 2024 | News

China’s Leads Biolabs Secures FDA Orphan Drug Designation for LBL-034 in Multiple Myeloma Treatment

Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-034, a humanized bispecific T-cell engaging antibody target...

November 07, 2024 | News

Medidata Introduces Oncology and Vaccine Solutions to Streamline Phase II and III Trials with FDA-Aligned Patient-Centric Design

The new products combine Medidata's diverse technologies and experience from thousands of previous trials to streamline the management of Phase II an...

November 05, 2024 | News

Breast Cancer Drug Shows Promise for Treating Hereditary Hemorrhagic Telangiectasia, a Rare Vascular Disorder

A drug commonly used to treat breast cancer might be able to help people living with hereditary hemorrhagic telangiectasia (HHT) – a rare genetic ble...

November 05, 2024 | News

Senhwa Biosciences Appoints Dr. Yiu-Lian Fong to Board of Directors for Strategic Growth in Oncology and Precision Medicine

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...

November 04, 2024 | News

Taiwan’s CStone Secures UK Approval for Sugemalimab as First-Line Treatment for Metastatic NSCLC

This approval marks the second international marketing authorization for sugemalimab outside of China, following its recent approval by the Eur...

November 01, 2024 | News

Taiwan’s Formosa Pharmaceuticals Partners with Portugal’s DÁVI Farmacêutica to Introduce APP13007 for Post-Surgical Ocular Pain Relief in Europe

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with DÁVI Far...

November 01, 2024 | News

Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology

In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...

November 01, 2024 | Interview

Hong Kong’s Akeso Biopharma Enrolls First Patient in Pioneering Phase III Trial for Advanced Head and Neck Cancer Therapy

Akeso Biopharma (9926.HK) is pleased to announce the enrollment of the first patient in its randomized, controlled, multicenter Phase III clinical study (A...

October 31, 2024 | News

GC Biopharma and Novelty Nobility Join Forces to Develop New Antibody Therapy for Geographic Atrophy in Age-Related Macular Degeneration

GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therapeut...

October 29, 2024 | News

RAPT Therapeutics Boosts Drug Development Efficiency with INTEGRA Biosciences’ Pipettes for Cancer and Inflammatory Disease Research

RAPT Therapeutics in San Francisco, USA, relies on INTEGRA Biosciences’ pipettes to seamlessly accelerate the development of its candidate small...

October 23, 2024 | News